MiniMed Group, Inc.
About MiniMed Group, Inc.
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2026
- $2.3B
- Net income
- -$148.0M
- Total assets
- $4.3B
- Market cap
- $4.0B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $4.0B
- Shares outstanding
- 271.7M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Mar 6, 2026
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Reported a net loss of $148.0M in FY2026.
- Trading 20% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review MiniMed Group, Inc..
Write a review
News about MiniMed Group, Inc.
News & sentiment via Polygon.io
